Back
Kairos Pharma Quote, Financials, Valuation and Earnings
Sponsored
KAPA
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14
KAPA
Kairos Pharma
Last Price:
1.61
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Kairos Pharma Price Quote
$1.61
+0.01 (+7.33%)
(Updated: November 23, 2024 at 5:41 AM ET)
Kairos Pharma Key Stats
Sell
14
Kairos Pharma (KAPA)
is a Sell
Day range:
$1.41 - $1.87
52-week range:
$1.22 - $4.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
255.5K
Avg. volume:
508.2K
1-year change:
0%
Market cap:
$20.5M
Revenue:
$0
EPS:
$-0.19
How Much Does Kairos Pharma Make?
Data Unavailable
Is Kairos Pharma Growing As A Company?
Data Unavailable
Kairos Pharma Stock Price Performance
-
Did Kairos Pharma Stock Go Up Last Month?
Kairos Pharma share price went up by 10.34% last month -
Did KAPA's Share Price Rise Over The Last Year?
KAPA share price rose by 0% over the past 1 year
What Is Kairos Pharma 52-Week High & Low?
-
What Is Kairos Pharma’s 52-Week High Share Price?
Kairos Pharma has traded as high as $4.00 over the past 52 weeks -
What Is Kairos Pharma’s 52-Week Low Share Price?
Kairos Pharma has traded as low as $1.22 over the past 52 weeks
Kairos Pharma Price To Free Cash Flow
-
Is Kairos Pharma Stock Overvalued?
Kairos Pharma is trading at a price to free cash flow ratio of 714.56 -
Is Kairos Pharma Stock Undervalued?
Kairos Pharma EV to Free Cash Flow ratio is 821.04 -
What Is Kairos Pharma’s Price Earnings Growth Ratio?
KAPA PEG ratio is 0.00 -
Is Kairos Pharma Trading At A Premium To Earnings?
Kairos Pharma EV to EBIT ratio is 0.00
Is It Risky To Buy Kairos Pharma?
-
How Much Debt Does Kairos Pharma Have?
Total long term debt quarterly is $0 -
How Much Cash Does Kairos Pharma Have?
Cash and short term investments quarterly total is $21K -
What Is Kairos Pharma’s Book Value Per Share?
Book value per share is -0.07
Is Kairos Pharma Cash Flow Positive?
-
What Is KAPA Cash Flow From Operations?
Cash flow from operations (TTM) is $25K -
What Is Kairos Pharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$236K -
What Is Kairos Pharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Kairos Pharma Return On Invested Capital
Data Unavailable
Kairos Pharma Earnings Date & Stock Price
-
What Is Kairos Pharma's Stock Price Today?
A single share of KAPA can be purchased today for 1.60 -
What Is Kairos Pharma’s Stock Symbol?
Kairos Pharma trades on the nyam under the ticker symbol: KAPA -
When Is Kairos Pharma’s Next Earnings Date?
The next quarterly earnings date for Kairos Pharma is scheduled on November 29, 2024 -
When Is KAPA's next ex-dividend date?
Kairos Pharma's next ex-dividend date is November 23, 2024 -
How To Buy Kairos Pharma Stock?
You can buy Kairos Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Kairos Pharma Competitors
-
Who Are Kairos Pharma's Competitors?
Below is a list of companies who compete with Kairos Pharma or are related in some way:
Kairos Pharma Dividend Yield
-
What Is KAPA Dividend Yield?
Kairos Pharma’s dividend yield currently is 0% -
What Is Kairos Pharma’s Payout Ratio?
Kairos Pharma’s payout ratio is 0% -
When Did Kairos Pharma Last Pay A Dividend?
The latest dividend pay date is November 23, 2024 -
What Is Kairos Pharma’s Dividend Per Share?
Kairos Pharma pays a dividend of $0.00 per share
Kairos Pharma Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -400% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 9.00 |
Upside from Last Price: | 462.5% |
Major Shareholders
Data Unavailable